Mark J. Poznansky, Ph.D., O.Ont., C.M.
President, G2G Consulting Inc.


B.Sc. (Physiology) McGill University
1970  Ph.D.(Physiology) McGill University
1972  Postdoc (Biophysics), Harvard Medical School
2009 Programs on Negotiation, Harvard Law School

Positions Held:

2008-            Chairman of the Board, Ontario Genomics Institute
2008-            Chairman of the Board, Let’s Talk Science
1993-2007     President, CEO and Scientific Director, Robarts Research Institute      
2003-2004     President and CEO, Viron Therapeutics Inc. London, Ontario
1984-1993     Associate Dean of Medicine (Research), Faculty of Medicine, University of  Alberta, Edmonton
1982-1993     Professor of Physiology, Lipid and Lipoprotein Research group, University  of Alberta, Edmonton
1976-1982     Associate Professor, Physiology, University of Alberta
1973-1974     Charge de Recherche, College de France, Paris
1970-1976     Lecturer/Instructor in Biophysics, Harvard Medical School

Scholarly Activity:

75 peer reviewed publications
5 book chapters
Over $2.5M in Research funding


United States Patent No. 4,749,570
Targeting Conjugates of Albumin and Therapeutic Agents.
Canadian Patent No. 1,168,150.
Targeting Conjugates of Albumin and Therapeutic Agents.
United States Patent Superoxide Dismutase (SOD) ‑ Catalase Conjugates.

Board Experience:

Robarts Research Institute, President and CEO
The Siebens-Drake Research Institute, Scientific Director
Canadian Medical Discoveries Fund, Chair, Scientific Advisory Board
MDS Capital Corp., Chair, Scientific Advisory Board
University Medical Discoveries Inc., Founding Board Member
Med-Tech Partners, Founding Board Member     
Council for Health Research in Canada, Founding Member and Chair
Research Canada, Founding Member
The Canadian Medical Hall of Fame, Founding Member
Ontario Genomics Institute, Vice Chair & Chair
Ontario Health Research Alliance, Board Executive
Council of Ontario Research Directors, Co-Chair
The Coalition for Biomedical and Health Research, Founding Member
Viron Therapeutics Inc., Founding Board Member (1997)
Viron Therapeutics Inc., President & CEO (2003/04)
London Biotechnology Incubator, Founding Member
Stressgen/Genzyme, Joint Partnership, Board Member
Diabetogen Inc., Board Member
BioMark Inc., Board Member
TechAlliance, London, Board Member
Ontario Genomics Institute, Chairman (current)
Thunder Bay Regional Research Institute, Chief Science Advisor (current)
Let’s Talk Science, Chairman (current)
Innovation Institute of Ontario, Board Member

Major Committees and Administrative Responsibilities:

NIH Study Sections on Electrochemistry, Glucose Sensors and Microencapsulation
Alberta Heart Foundation, Science Advisory Committee (1978‑1989)
Canadian Heart Foundation, Science Advisory Committee
Alberta Heritage Foundation for Medical Research, Grants Panel
Northern Alberta Children's Hospital Foundation, Board of Directors Joint Planning Committee:
  Paediatric Research Institute, Steering Committee
Alberta Heritage Medical Research Building, Chairman, Faculty of Medicine Planning and Priorities Committee
Alberta Heritage Foundation for Medical Research, Grants Panel, Technology Transfer
Association of Canadian Medical Colleges Research Committee
VIII World Congress of the International Society for Artificial Organs
Medical Research Council Grants Panel
Canadian Foundation for Innovation, panel chair